AJP - Regulatory, Integrative and Comparative Physiology, Vol 273, Issue 4 1283-R1290, Copyright © 1997 by American Physiological Society

ARTICLES

Key role for cyclooxygenase-2 in PGE2 and PGF2alpha receptor regulation and cerebral blood flow of the newborn

D. Y. Li, P. Hardy, D. Abran, A. K. Martinez-Bermudez, A. M. Guerguerian, M. Bhattacharya, G. Almazan, R. Menezes, K. G. Peri, D. R. Varma and S. Chemtob
Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.

Ibuprofen, a cyclooxygenase (COX) inhibitor nonselective for either COX-1 or COX-2 isoform, upregulates cerebrovascular prostaglandin E2 (PGE2) and PGF2alpha receptors in newborn pigs. COX-2 was shown to be the predominant form of COX and the main catalyst of prostaglandin synthesis in the newborn brain. We proceeded to establish direct evidence that COX-2-generated prostaglandins govern PGE2 and PGF2alpha receptor density and function in the cerebral vasculature of the newborn. Hence, we determined PGE2 and PGF2alpha receptor density and functions in brain vasculature by using newborn pigs treated with saline, ibuprofen, COX-1 inhibitor (valerylsalicylate), or COX-2 inhibitors (DUP-697 and NS-398). Newborn brain PGE2 and PGF2alpha concentrations were significantly reduced by ibuprofen, DUP-697, and NS-398 but not by valerylsalicylate. In newborn pigs treated with DUP-697, NS-398, and ibuprofen, PGE2 and PGF2alpha receptor densities in brain microvessels were increased to adult levels; there was also a significant increase in inositol 1,4,5-trisphosphate (IP3) production and cerebral vasoconstrictor effects of 17-phenyl trinor PGE2 (EP1 receptor agonist), M&B-28767 (EP3 receptor agonist), PGF2alpha, and fenprostalene (PGF2alpha analog). Treatment with ibuprofen or DUP-697 also increased the upper blood pressure limit of cerebral cortex and periventricular blood flow autoregulation from 85 to > or = 125 mmHg (uppermost blood pressure studied). However, valerylsalicylate treatment did not affect cerebrovascular PGE2 and PGF2alpha receptors, IP3 production, or vasoconstrictor effects in newborn animals. These in vivo and in vitro observations indicate that COX-2 is mainly responsible for the regulation of PGE2 and PGF2alpha receptors and their functions in the newborn cerebral vasculature.

This article has been cited by other articles:

				L. Rihakova, C. Quiniou, F. F. Hamdan, R. Kaul, S. Brault, X. Hou, I. Lahaie, P. Sapieha, D. Hamel, Z. Shao, et al. VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonist Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2009; 297(4): R1009 - R1018. [Abstract] [Full Text] [PDF]

				D. L. Shawcross, S. Balata, S. W. M. Olde Damink, P. C. Hayes, J. Wardlaw, I. Marshall, N. E. P. Deutz, R. Williams, and R. Jalan Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia Am J Physiol Gastrointest Liver Physiol, September 1, 2004; 287(3): G503 - G509. [Abstract] [Full Text] [PDF]

				D. H. Wright, D. Abran, M. Bhattacharya, X. Hou, S. G. Bernier, A. Bouayad, J.-C. Fouron, A. Vazquez-Tello, M. H. Beauchamp, R. I. Clyman, et al. Prostanoid receptors: ontogeny and implications in vascular physiology Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1343 - R1360. [Abstract] [Full Text] [PDF]

				X. Hou, L. J. Roberts II, D. F. Taber, J. D. Morrow, K. Kanai, F. Gobeil Jr., M. H. Beauchamp, S. G. Bernier, G. Lepage, D. R. Varma, et al. 2,3-Dinor-5,6-dihydro-15-F2t-isoprostane: a bioactive prostanoid metabolite Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R391 - R400. [Abstract] [Full Text] [PDF]

				R. Nasrallah, O. Laneuville, S. Ferguson, and R. L. Hebert Effect of COX-2 inhibitor NS-398 on expression of PGE2 receptor subtypes in M-1 mouse CCD cells Am J Physiol Renal Physiol, July 1, 2001; 281(1): F123 - F132. [Abstract] [Full Text] [PDF]

				I. Dumont, P. Hardy, K. G. Peri, X. Hou, S. Molotchnikoff, D. R. Varma, and S. Chemtob Regulation of endothelial nitric oxide synthase by PGD2 in the developing choroid Am J Physiol Heart Circ Physiol, January 1, 2000; 278(1): H60 - H66. [Abstract] [Full Text] [PDF]

				I. Dumont, X. Hou, P. Hardy, K. G. Peri, M. Beauchamp, T. Najarian, S. Molotchnikoff, D. R. Varma, and S. Chemtob Developmental Regulation of Endothelial Nitric Oxide Synthase in Cerebral Vessels of Newborn Pig by Prostaglandin E2 J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 627 - 633. [Abstract] [Full Text]

				I. Dumont, K. G. Peri, P. Hardy, X. Hou, A. K. Martinez-Bermudez, S. Molotchnikoff, D. R. Varma, and S. Chemtob PGE2, via EP3 receptors, regulates brain nitric oxide synthase in the perinatal period Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1998; 275(6): R1812 - R1821. [Abstract] [Full Text] [PDF]

				F. Gobeil Jr, I. Dumont, A. M. Marrache, A. Vazquez-Tello, S. G. Bernier, D. Abran, X. Hou, M. H. Beauchamp, C. Quiniou, A. Bouayad, et al. Regulation of eNOS Expression in Brain Endothelial Cells by Perinuclear EP3 Receptors Circ. Res., April 5, 2002; 90(6): 682 - 689. [Abstract] [Full Text] [PDF]